These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 8561142
41. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Ali RA, Dooley C, Comber H, Newell J, Egan LJ. Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283 [Abstract] [Full Text] [Related]
42. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Ananthakrishnan AN, McGinley EL, Binion DG. Am J Gastroenterol; 2008 Nov; 103(11):2789-98. PubMed ID: 18684184 [Abstract] [Full Text] [Related]
43. Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Longobardi T, Jacobs P, Bernstein CN. Am J Gastroenterol; 2004 Apr; 99(4):650-5. PubMed ID: 15089897 [Abstract] [Full Text] [Related]
44. Risk of arterial thrombotic events in inflammatory bowel disease. Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858 [Abstract] [Full Text] [Related]
45. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study. Otani T, Iwasaki M, Yamamoto S, Sobue T, Hanaoka T, Inoue M, Tsugane S, Japan Public Health Center-based Prospective Study Group. Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1492-500. PubMed ID: 14693743 [Abstract] [Full Text] [Related]
46. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974 [Abstract] [Full Text] [Related]
47. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B. Hepatogastroenterology; 1998 Jan; 45(24):2064-72. PubMed ID: 9951867 [Abstract] [Full Text] [Related]
48. Oral contraceptive use and risk of colorectal cancer. Fernandez E, La Vecchia C, Franceschi S, Braga C, Talamini R, Negri E, Parazzini F. Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422 [Abstract] [Full Text] [Related]
49. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507 [Abstract] [Full Text] [Related]
50. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China]. Zhang YZ, Sheng JQ, Li SR, Wu ZT. Zhonghua Yi Xue Za Zhi; 2005 Nov 09; 85(42):2995-3000. PubMed ID: 16324388 [Abstract] [Full Text] [Related]
51. Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study. Bernstein CN, Nugent Z, Longobardi T, Blanchard JF. Am J Gastroenterol; 2009 Nov 09; 104(11):2774-8. PubMed ID: 19623167 [Abstract] [Full Text] [Related]
53. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Gastroenterology; 2012 Aug 09; 143(2):382-9. PubMed ID: 22609382 [Abstract] [Full Text] [Related]
54. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM. Scand J Gastroenterol; 2012 Sep 09; 47(8-9):1021-9. PubMed ID: 22577871 [Abstract] [Full Text] [Related]
55. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Lutgens M, Vermeire S, Van Oijen M, Vleggaar F, Siersema P, van Assche G, Rutgeerts P, Oldenburg B, Dutch Initiative on Crohn and Colitis. Clin Gastroenterol Hepatol; 2015 Jan 09; 13(1):148-54.e1. PubMed ID: 25041864 [Abstract] [Full Text] [Related]
56. Impact of autonomic dysfunction on inflammatory bowel disease. Ananthakrishnan AN, Issa M, Barboi A, Jaradeh S, Zadvornova Y, Skaros S, Johnson K, Otterson MF, Binion DG. J Clin Gastroenterol; 2010 Apr 09; 44(4):272-9. PubMed ID: 19727003 [Abstract] [Full Text] [Related]
57. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. Manninen P, Karvonen AL, Huhtala H, Aitola P, Hyöty M, Nieminen I, Hemminki H, Collin P. J Crohns Colitis; 2013 Dec 09; 7(11):e551-7. PubMed ID: 23619008 [Abstract] [Full Text] [Related]
58. IBD-related carcinoma and lymphoma. Claessen MM, Siersema PD, Vleggaar FP. Best Pract Res Clin Gastroenterol; 2011 Apr 09; 25 Suppl 1():S27-38. PubMed ID: 21640928 [Abstract] [Full Text] [Related]
59. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. Gastroenterology; 2010 Oct 09; 139(4):1128-37. PubMed ID: 20600026 [Abstract] [Full Text] [Related]
60. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). Peyrin-Biroulet L, Lepage C, Jooste V, Guéant JL, Faivre J, Bouvier AM. Inflamm Bowel Dis; 2012 Dec 09; 18(12):2247-51. PubMed ID: 22467511 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]